These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29246775)

  • 21. Tafamidis: A Review in Transthyretin Amyloidosis with Polyneuropathy.
    Lamb YN; Deeks ED
    Drugs; 2019 Jun; 79(8):863-874. PubMed ID: 31098895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A genealogical and clinical study of the phenotypical variation within the Swedish transthyretin His88Arg (p. His108Arg) amyloidosis family.
    Hellman U; Lundgren HE; Westermark P; Stafberg C; Nahi H; Tachlinski S; Guggi M; Flogegård M; Hamid M; Escher SA; Suhr OB
    Eur J Med Genet; 2015 Apr; 58(4):211-5. PubMed ID: 25721874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transthyretin (ATTR) amyloidosis nephropathy: lessons from a TTR stabilizer molecule.
    Rocha A; Silva A; Cardoso M; Beirão I; Alves C; Teles P; Coelho T; Lobato L
    Amyloid; 2017 Mar; 24(sup1):81-82. PubMed ID: 28434370
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical and histopathological features of progressive-type familial amyloidotic polyneuropathy with TTR Lys54.
    Nagasaka T; Togashi S; Watanabe H; Iida H; Nagasaka K; Nakamura Y; Miwa M; Kobayashi F; Shindo K; Shiozawa Z
    J Neurol Sci; 2009 Jan; 276(1-2):88-94. PubMed ID: 18930252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis.
    Coelho T; Maurer MS; Suhr OB
    Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy.
    Coelho T; Maia LF; da Silva AM; Cruz MW; Planté-Bordeneuve V; Suhr OB; Conceiçao I; Schmidt HH; Trigo P; Kelly JW; Labaudinière R; Chan J; Packman J; Grogan DR
    J Neurol; 2013 Nov; 260(11):2802-14. PubMed ID: 23974642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease.
    Adams D; Koike H; Slama M; Coelho T
    Nat Rev Neurol; 2019 Jul; 15(7):387-404. PubMed ID: 31209302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of tafamidis on transthyretin stabilization and clinical outcomes in patients with non-Val30Met transthyretin amyloidosis.
    Merlini G; Planté-Bordeneuve V; Judge DP; Schmidt H; Obici L; Perlini S; Packman J; Tripp T; Grogan DR
    J Cardiovasc Transl Res; 2013 Dec; 6(6):1011-20. PubMed ID: 24101373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring treatment response to tafamidis by serial native T1 and extracellular volume in transthyretin amyloid cardiomyopathy.
    Shintani Y; Okada A; Morita Y; Hamatani Y; Amano M; Takahama H; Amaki M; Hasegawa T; Ohta-Ogo K; Kanzaki H; Ishibashi-Ueda H; Yasuda S; Shimazaki C; Yoshinaga T; Yazaki M; Sekijima Y; Izumi C
    ESC Heart Fail; 2019 Feb; 6(1):232-236. PubMed ID: 30478886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three Turkish families with different transthyretin mutations.
    Bekircan-Kurt CE; Güneş N; Yılmaz A; Erdem-Özdamar S; Tan E
    Neuromuscul Disord; 2015 Sep; 25(9):686-92. PubMed ID: 26115788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tafamidis for the treatment of transthyretin amyloidosis.
    Lorenzini M; Elliott PM
    Future Cardiol; 2019 Mar; 15(2):53-61. PubMed ID: 30767672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [What gnaws at the heart and gets on the nerves].
    Kristen AV
    Internist (Berl); 2018 Nov; 59(11):1208-1213. PubMed ID: 30039176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcumin could reduce the monomer of TTR with Tyr114Cys mutation via autophagy in cell model of familial amyloid polyneuropathy.
    Li H; Zhang Y; Cao L; Xiong R; Zhang B; Wu L; Zhao Z; Chen SD
    Drug Des Devel Ther; 2014; 8():2121-8. PubMed ID: 25382970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G).
    Klaassen SHC; Lemmink HH; Bijzet J; Glaudemans AWJM; Bos R; Plattel W; van den Berg MP; Slart RHJA; Nienhuis HLA; van Veldhuisen DJ; Hazenberg BPC
    Cardiovasc Pathol; 2017; 29():19-22. PubMed ID: 28460244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of transthyretin familial amyloid polyneuropathy with tafamidis: a case report].
    Miyazaki Y
    Nihon Ronen Igakkai Zasshi; 2017; 54(1):75-80. PubMed ID: 28202889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tafamidis concentration required for transthyretin stabilisation in cerebrospinal fluid.
    Tsai FJ; Jaeger M; Coelho T; Powers ET; Kelly JW
    Amyloid; 2023 Sep; 30(3):279-289. PubMed ID: 36691999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel transthyretin gene mutation in familial amyloid neuropathy in India: Case.
    Rohatgi S; Nirhale S; Manohar P; Rao P; Naphade P; Khan FMA; Dave D; Sravya Kotaru VV; Gupta S; Gitay A; Dubey P
    Ann Afr Med; 2022; 21(3):296-298. PubMed ID: 36204920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal evolution of ventricular function and cardiac magnetic resonance imaging tissue characteristics in tafamidis-treated transthyretin amyloid cardiomyopathy.
    Dobner S; Bernhard B; Wieser M; Wahl A; Stark AW; Köchli V; Spano G; Boscolo Berto M; Johner C; Elchinova E; Tanner G; Safarkhanlo Y; Stortecky S; Schütze J; Hunziker Munsch L; Gräni C
    Amyloid; 2024 Jun; 31(2):145-147. PubMed ID: 38069637
    [No Abstract]   [Full Text] [Related]  

  • 39. Familial amyloid polyneuropathy.
    Adams D; Cauquil C; Labeyrie C
    Curr Opin Neurol; 2017 Oct; 30(5):481-489. PubMed ID: 28678039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
    Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.